NCT06114719CompletedPhase 3
Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery
The Effect of Silymarin on the Prevention of Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Source: ClinicalTrials.gov · Last updated 4 Dec 2024
Brief summary (registry, in English)
The study is a prospective, randomized, controlled trial to assess the effects of silymarin on the occurrence of postoperative atrial fibrillation after coronary artery bypass graft surgery.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (actual)
- First submitted
- 29 Oct 2023
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Sept 2024
- Lead sponsor
- University of Novi Sad
- Diseases
- Atrial fibrillation
- NCT number
- NCT06114719
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 160
- From 1 Jan 2023 to the primary completion date, 1 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous history of interventionally treated arrhythmias
Other illness
- end-stage renal disease requiring hemodialysis
- chronic inflammatory and neoplastic diseases
Other
- preoperative atrial fibrillation
Who the study is looking for
- scheduled for elective CABG surgery using cardiopulmonary bypass
- first cardiac surgery
- left ventricular ejection fraction \> 35%
- less than moderate mitral regurgitation
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Cardiovascular Diseases of Vojvodina Coordinator of this site? Confirm its status | Kamenitz | Serbia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.